Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool.
Javier García-Campayo, Enric Zamorano, Miguel A Ruiz...
https://pubmed.ncbi.nlm.nih.gov/20089179/Actively Recruiting
Led by Universidad de Córdoba · Updated on 2026-10-02
184
Participants Needed
2
Research Sites
13 weeks
Total Duration
Researchers are evaluating the effectiveness of different brief psychological treatments for people experiencing mild to moderate emotional symptoms such as anxiety, depression, and somatization. This randomized clinical trial compares ultra-brief four sessions and brief eight sessions formats of transdiagnostic cognitive-behavioral therapy TD-CBT delivered either in group or individual settings. The study also includes an active comparator group receiving relaxation therapy. The goal is to understand which treatment format works best and the emotional regulation processes involved in improvement. Participants are randomly assigned to one of four groups ultra-brief group TD-CBT, brief group TD-CBT, individual ultra-brief TD-CBT, or group relaxation therapy. The TD-CBT sessions focus on psychoeducation, emotion regulation, behavioral activation, problem-solving, and exposure techniques, with between-session exercises to support skill practice. Group sessions are typically 90 minutes, while individual sessions last about 60 minutes. The relaxation group participates in a four-session muscle relaxation program based on Jacobsons technique. During the study, participants complete several questionnaires assessing depression, anxiety, somatic symptoms, emotional regulation, therapeutic alliance, and treatment satisfaction. Assessments occur at baseline, immediately after treatment, and at 3 and 6 months follow-up. Researchers also collect sociodemographic information and healthcare use data. The study monitors progress through validated scales like the PHQ-9, GAD-7, and PHQ-15 to evaluate changes in emotional symptoms over time.
CONDITIONS
Ultra-brief Psychological Treatments for Emotional Symptoms and Disorders
J
Juan Antonio Moriana Elvira Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Universidad de Córdoba
Lead Sponsor
State Research Agency, Spain
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 4 to 8 weeks depending on the group
Participants receive their assigned therapy in one of four groups: ultra-brief group cognitive-behavioral therapy, brief group cognitive-behavioral therapy, individual ultra-brief cognitive-behavioral therapy, or group relaxation therapy. Sessions occur weekly or every two weeks depending on the group.
Weekly or biweekly sessions
Duration - 6 months
Participants complete questionnaires to assess emotional symptoms and treatment effects at 3 and 6 months after treatment ends.
2 follow-up assessments
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Javier García-Campayo, Enric Zamorano, Miguel A Ruiz...
https://pubmed.ncbi.nlm.nih.gov/20089179/Ingvild Finsrud, Helene A Nissen-Lie, Karianne Vrabel...
https://pubmed.ncbi.nlm.nih.gov/33938407/C Diez-Quevedo, T Rangil, L Sanchez-Planell...
https://pubmed.ncbi.nlm.nih.gov/11485122/Roger Muñoz-Navarro, Antonio Cano-Vindel, Leonardo Adrián Medrano...
https://pubmed.ncbi.nlm.nih.gov/28793892/S Ros Montalbán, A Comas Vives, M Garcia-Garcia
https://pubmed.ncbi.nlm.nih.gov/21188674/R L Spitzer, K Kroenke, J B Williams
https://pubmed.ncbi.nlm.nih.gov/10568646/Roger Muñoz-Navarro, Antonio Cano-Vindel, Juan Antonio Moriana...
https://pubmed.ncbi.nlm.nih.gov/28666201/Frank W Bond, Steven C Hayes, Ruth A Baer...
https://pubmed.ncbi.nlm.nih.gov/22035996/Universidad de Córdoba
Lead Sponsor
State Research Agency, Spain
Collaborating Sponsor